Risk of Coronavirus Disease 2019 Messenger RNA Vaccination-Associated Myocarditis and Pericarditis - A Systematic Review of Population-Based Data

Lin, Yen-ChingYen-ChingLinCHIA-HSUIN CHANGSu, Wei-JuWei-JuSuYang, Chin-HuiChin-HuiYangJANN-TAY WANG2023-12-112023-12-1120231179-1594https://scholars.lib.ntu.edu.tw/handle/123456789/637662Early studies showed that the risks of mRNA vaccine-associated myocarditis and pericarditis are low but with substantial variation across studies. Study characteristics, ethnicity, vaccine types, dose intervals, and SARS-CoV-2 infection prevalence may influence the rates of myocarditis and pericarditis after mRNA vaccination in population-based studies.enCOVID-19; mRNA vaccine; myocarditis; population-based study; surveillance dataRisk of Coronavirus Disease 2019 Messenger RNA Vaccination-Associated Myocarditis and Pericarditis - A Systematic Review of Population-Based Datajournal article10.2147/RMHP.S422372378410762-s2.0-85174181919https://api.elsevier.com/content/abstract/scopus_id/85174181919